E0298 Intensive Cholesterol Lowering With Simvastatin Improves Outcomes of Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome

Heart - United Kingdom
doi 10.1136/hrt.2010.208967.298
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Predictors of Mortality in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Heart
2003English

Long-Term Outcomes of Very Elderly Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome

Heart Lung and Circulation
Respiratory MedicinePulmonaryCardiovascular MedicineCardiology
2019English

Percutaneous Coronary Intervention in Patients With Anomalous Origin of Coronary Artery Presenting With Acute Coronary Syndrome: A Case Series

Journal of Cardiovascular Disease Research
Cardiovascular MedicineCardiology
2013English

Protection Against Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Angiology
Cardiovascular MedicineCardiology
2018English

Erythropoietin in Patients With Acute Coronary Syndrome and Its Cardioprotective Action After Percutaneous Coronary Intervention

Circulation Journal
MedicineCardiovascular MedicineCardiology
2009English

Rationale and Role of High Loading Dose Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Pharmacology & Pharmacy
2012English

Association of Serum miR-186-5p With the Prognosis of Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention

Frontiers in Physiology
Physiology
2019English

Surgical vs Percutaneous Coronary Revascularization in Patients With Diabetes Following an Acute Coronary Syndrome

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2019English

Clinical Economy Efficacy of Targeted Approach to Acute Coronary Syndrome Patients Management With Percutaneous Intervention

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy